Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

0.8178
-0.1122-12.06%
Post-market: 0.8044-0.0134-1.64%19:53 EDT
Volume:575.30K
Turnover:496.74K
Market Cap:12.88M
PE:-0.64
High:0.9247
Open:0.9100
Low:0.8001
Close:0.9300
52wk High:7.20
52wk Low:0.4606
Shares:15.74M
Float Shares:8.26M
Volume Ratio:1.77
T/O Rate:6.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2684
EPS(LYR):-1.9700
ROE:-399.51%
ROA:-81.85%
PB:-11.66
PE(LYR):-0.42

Loading ...

Calcimedica Announces Annual Shareholder Meeting

Reuters
·
5 hours ago

Calcimedica Files Initial Beneficial Ownership Statement for Alafi Capital Co LLC

Reuters
·
Jul 11

Calcimedica Files Form 3 Initial Beneficial Ownership Statement for Director Evgeny Zaytsev

Reuters
·
Jul 08

CalciMedica Announces Board Expansion and Leadership Transition

TIPRANKS
·
Jul 08

Calcimedica Names Evgeny Zaytsev to Board as Director Expands to Eight Members

Reuters
·
Jul 08

Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000

Reuters
·
Jun 29

CalciMedica Advances Auxora After Favorable FDA Safety Review

TIPRANKS
·
Jun 25

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

TIPRANKS
·
Jun 25

CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review

MT Newswires Live
·
Jun 24

CalciMedica Amends Loan, Issues New Equity Warrants

TIPRANKS
·
Jun 24

CalciMedica announces $49M private placement

TIPRANKS
·
Jun 24

Calcimedica - Proceeds to Support Phase 1B Auxora Study in Pah and Cm5480 Ind Clearance, Data Expected Mid-2027

THOMSON REUTERS
·
Jun 24

Calcimedica - Anticipates Cash Runway into Second Half of 2027 with Upfront Proceeds

THOMSON REUTERS
·
Jun 24

Calcimedica Announces Private Placement Financing for up to Approximately $49 Million to Advance Pulmonary Hypertension Program

THOMSON REUTERS
·
Jun 24

Calcimedica - FDA Review Allows Calcimedica to Continue Dosing Auxora in Kourage Trial

THOMSON REUTERS
·
Jun 24

Calcimedica Announces Clinical Development of Auxora May Proceed Following FDA Review of Kourage Trial Interim Safety Data

THOMSON REUTERS
·
Jun 24

Calcimedica - Expects FDA Feedback on Auxora Pancreatitis Program in Q3 2026

THOMSON REUTERS
·
Jun 24

Calcimedica - Lender Extends Interest-only Period to Sept 30, 2027 and Maturity to Sept 1, 2029 - SEC Filing

THOMSON REUTERS
·
Jun 24

Calcimedica - Enters First Amendment to Loan and Security Agreement on June 23, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 24

Calcimedica Issues Unregistered Warrant to Buy 1,000,000 Shares at USD 1 Each

Reuters
·
Jun 24